LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL1154 | Name | LINC01612 | Aliases | RP11-789C1.1 | |
Species | Homo sapiens | Chromosome | 4 | Start site | 170273919 | |
End site | 170283079 | Chain | plus | Exon NO. | N/A | |
Assembly | Ensembl Release 89 | Class | lincRNA | NCBI accession | N/A | |
Ensembl | ENSG00000250266 | Sequence | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
gastric cancer | microarray, qPCR etc. | gastric cancer tissue | down-regulated | interaction | The expression levels of six up-regulated lncRNAs (XLOC_010235, CACNAICAS3, INTS7, AC104699.1, TSNAX-DISC1, and PRSS21) and six down-regulated lncRNAs (RP11-789C1.1, RP11-528G1.2, MYLK-AS1, RP11-643M14.1, GS1-5L10.1, and AP001439.2) were determined by using qPCR. | 26045391 | Lnc2Cancer | ||
Interaction | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
XLOC_010235 | RNA-RNA | co-expression | Via survival analysis, patients who had high-expressed XLOC_010235 or low-expressed RP11-789C1.1 showed significantly worse survival than patients with inverse-expressed XLOC_010235 or RP11-789C1.1. | 26045391 | |||||